![This Week in Cardiology artwork](https://is4-ssl.mzstatic.com/image/thumb/Podcasts113/v4/44/af/76/44af7613-b3cb-6d01-f01a-53b09a9a0fcf/mza_3081219587113728202.png/100x100bb.jpg)
May 17 2024 This Week in Cardiology
This Week in Cardiology
English - May 17, 2024 20:17 - 29 minutes - 27.4 MB - ★★★★★ - 744 ratingsScience Health & Fitness Medicine cardiology health medicine clinicaltrials eartrhythmdisorder electrophysiologist endoflifecare expertcommentary healthnews internalmedicine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
An Impella update, another TAVI vs SAVR trial, two studies on angina and PCI, another null substudy from REVIVED-BCIS, and semaglutide are the topics John Mandrola, MD, covers in this week’s podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I. Impella Update
CHRIP BCIS 3 https://classic.clinicaltrials.gov/ct2/show/NCT05003817 Danger-Shock Podcast https://www.medscape.com/viewarticle/1000675II. TAVI vs SAVR
Notion 2 Trial EHJ https://doi.org/10.1093/eurheartj/ehae331 DEDICATE-DZHK6III. Angina and PCI
Orbita 2 Sub-analysis Orbita Star https://www.jacc.org/doi/10.1016/j.jacc.2024.04.001IV. Complete Revascularization
Main REVIVED trial https://www.nejm.org/doi/full/10.1056/NEJMoa2206606 JACC Substudy https://www.jacc.org/doi/10.1016/j.jacc.2024.04.043V. Semaglutide
Semaglutide CV Benefits Irrespective of Weight Loss: 4-Year SELECT Data
https://www.medscape.com/viewarticle/semaglutide-cv-benefits-irrespective-weight-loss-4-year-2024a100095z
Nature Med substudy https://www.nature.com/articles/s41591-024-02996-7 SELECT Main paper https://www.nejm.org/doi/full/10.1056/NEJMoa2307563You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]